33
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Crear
Close
Create a timeline
Public timelines
Library
FAQ
Descargar
Export
Crear una copia
Premium
Insertar en el Sitio Web
Share
Ocular Therapeutix
Category:
Otro
Actualizado:
5 feb 2020
0
0
260
Autores
Created by
Nathan
Attachments
Comments
Eventos
Founded
Series A $1.17M (Undisclosed Investors)
Series B $6.09 M Pinnacle Ventures SV Health Investors Versant Venture Management
Series C $21.53 M Polaris Partners SV Health Investors Versant Venture Management
Series D $23.79 M Ascension Ventures Baxter Ventures Polaris Partners Sparta Capital Partners SV Health Investors Versant Venture Management
Debt $20 M Flexpoint Ford Silicon Valley Bank
IPO $65 M
Stock Drops 30%
Dextenza Approved
Períodos
Phase 2 Dextenza Post-Surgical Inflammation and Pain
Phase 3 Dextenza Post-Surgical Inflammation and Pain
About & Feedback
Acuerdo
Privacidad
Biblioteca
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments